PPCB Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...

Stats
Today's Volume	416 694
Average Volume	460 166
Market Cap	82.21B
EPS	$-0.0011
Earnings date	2022-11-14
P/E	-2.50
ATR14	$0.0010 (4.17%)

Propanc Biopharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Propanc Biopharma, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-28 366.00 (0.00%)
EPS:	$-0.0390

Q3	2023
Revenue:	$0
Gross Profit:	$-8 365.00 (0.00%)
EPS:	$-0.420

Q2	2023
Revenue:	$0
Gross Profit:	$-7 506.00 (0.00%)
EPS:	$-0.0005

Q1	2023
Revenue:	$0
Gross Profit:	$-6 373.00 (0.00%)
EPS:	$-0.0011

Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.